A panel of the Inquiry Committee approved a Consent Agreement under which the Registrant agreed to undertakings involving regular monitoring for fitness to practice nursing and a limitation on the type of shift they are permitted to work. The Registrant was identified by the agency's pharmacy auditing system has having suspicious transactions for Hydromorphone given as they were not typically providing direct patient care. The Registrant made admissions of diversion to the agency and BCCNM and sought treatment for a health condition. The Registrant provided an independent medical assessment documenting health concerns to BCCNM which could impact the ability to provide safe patient care. The independent medical assessment identified the Registrant is fit to practice nursing, and provided information regarding compliance with treatment recommendations.
The undertakings include, but are not limited to: regular reports from a medical monitoring agency regarding compliance with treatment recommendations, disclosure of treatment recommendations to relevant employer representative(s), and a limit on practice designed to prevent the circumstances leading to the practice concern from reoccurring. They have agreed to maintaining abstinence from all drugs of abuse, including certain over the counter substances. The abstinence is being monitored by a medical monitoring agency. The Registrant was also issued a reprimand for their conduct of diverting medication from the agency; they will also complete an ethics course.The Agreement will remain in place for a minimum of four years of continuous nursing practice.
The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition. The Inquiry Committee is satisfied that the undertakings will protect the public.